The global chromatography consumables market, valued at USD 5.6 billion in 2025, is projected to reach USD 6.0 billion in 2026 and USD 9.7 billion by 2035, representing a CAGR of 5.6% during the forecast period 2026 to 2035. In terms of product, columns hold the highest (around 45%) share of the current market. With respect to chromatography technique, liquid chromatography dominates the current market. In April 2026, Merck completed the acquisition of JSR Life Sciences’ chromatography busines...

The global agricultural biologicals market, valued at USD 16.62 billion in 2025, is projected to reach USD 18.27 billion in 2026 and USD 43.53 billion by 2035, representing a CAGR of 10.1% during the forecast period 2026 to 2035. In May 2026, IPL Biologicals opened its third manufacturing plant in Vadodara, Gujarat, raising its annual production capacity to 7,000 KL/year to strengthen its supply chain capabilities and meet the growing demand for these biologicals in India and export markets. In...

The next generation drug conjugates market, valued at USD 8.0 billion in 2025, is projected to reach USD 11.2 billion in 2026 and USD 26.2 billion by 2035, representing a CAGR of 9.9% during the forecast period 2026 to 2035. In terms of type of drug conjugate, ligand mediated RNAi conjugates hold the highest share (around 55%) of the current market. With respect to type of targeting ligand, next generation drug conjugates with amino sugar dominate (more than 60%) the current market.

The global AI in neurology market is expected to rise from USD 0.92 billion in 2026 and is projected to reach USD 12.81 billion by 2040, growing at a CAGR of 20.7% over the forecast period 2026 to 2040, driven by faster neuroimaging, clinical decision support, and precision neurology adoption. Based on offering, Software and Platforms capture 62.0% market share in 2026, whereas AI-Enabled Devices and Hardware registers a 22.4% CAGR through 2040, supported by expanding neurotechnology and closed-...

The global anti-aging drugs for dogs market, valued at USD 0.09 billion in 2026, is projected to reach USD 6.16 billion by 2040, with a 36% CAGR during the forecast period 2026 to 2040. Over the years, the pet dog population has increased at a substantial rate. According to the American Veterinary Medical Association, the dog population has steadily increased from 52.9 million in 1996 to 89.7 million in 2024. Also, the number of pet-owning households has increased from 31.3 million in 1996 to 59...

The global anti-obesity drugs market, valued at USD 28.2 billion in 2025, is projected to reach USD 45.1 billion in 2026 and USD 106.5 billion by 2035, representing a CAGR of 10.0% during the forecast period 2026 to 2035. In terms of route of administration, parenteral route captures the highest share of the current market.Based on the distribution channel, retail and online pharmacies are likely to capture the highest share of the current market. In terms of key geographical regions, North Amer...

The global implantable biosensors market is expected to rise from USD 2.90 billion in 2026 to reach USD 9.26 billion by 2040, growing at a CAGR of 8.6% over the forecast period 2026 to 2040, driven by long-duration continuous monitoring. Based on sensor type, electrophysiological sensors capture 37.0% market share in 2026, whereas electrochemical biosensors register a 9.9% CAGR through 2040, supported by longer-life metabolite sensing.

The global healthcare LLMOps market is expected to rise from USD 1.25 billion in 2026 to reach USD 22.40 billion by 2040, growing at a CAGR of 22.9% over the forecast period 2026 to 2040, driven by governed clinical AI workflows and agentic automation. Based on Deployment Mode, Public cloud deployment captures 49.0% market share in 2026, whereas Hybrid cloud deployment registers a 25.0% CAGR through 2040, as regulated workloads balance hyperscale AI with local controls. Based on Application / Us...

The global teleradiology services market, valued at USD 9.2 billion in 2025, is projected to reach USD 10.1 billion in 2026 and USD 23.3 billion by 2035, representing a CAGR of 9.7% during the forecast period 2026 to 2035. In terms of imaging modality, CT scan accounted for 35% of market revenues in 2026.With respect to end user, hospitals (51%) dominate the current market.

The global non-small cell lung cancer market size is estimated to grow from USD 23.8 billion in 2025 to USD 26.4 billion in 2026 and USD 56.0 billion by 2035, representing a CAGR of 8.7% during the forecast period. It is worth highlighting that among all the forms of non-small cell lung cancer, squamous cell carcinoma is one of the most common types and it may develop due to prolonged use of tobacco. In fact, the World Health Organization report shows that smoking is the main cause of lung cance...

The global female sexual dysfunction market reached USD 0.61 billion in 2026 and is projected to reach USD 2.87 billion by 2040, growing at a CAGR of 11.7% over the forecast period 2026 to 2040, driven by broader treatment eligibility and delivery innovation. Treatment demand is shifting from menopause-centered symptom management toward broader desire, arousal, pain, and orgasm-focused care. Estrogen therapy still leads drug demand with 41.0% share in 2026, while oral therapies hold 58.0% across...

The global clinical trial simulation market is expected to rise from USD 4.2 billion in 2026 to reach USD 11.8 billion by 2040, growing at a CAGR of 7.7% over the forecast period 2026 to 2040, driven by regulatory acceptance and AI-generated virtual patients. Based on application, dose and dosing-regimen optimization captures 24.0% market share in 2026, whereas synthetic or external control generation registers an 11.9% CAGR through 2040, supported by smaller trial cohorts. Based on end user, ph...

The global medication adherence market, valued at USD 5.45 billion in 2025, is projected to reach USD 6.08 billion in 2026 and USD 15.35 billion by 2035, representing a CAGR of 10.92% during the forecast period 2026 to 2035. In May 2026, Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, announced its participation at the BofA Securities 2026 Healthcare Conference. In January 2026, MIT engineers developed ingestible pills equipped with biod...

The global healthcare RAG market is expected to rise from USD 0.9 billion in 2026 and is projected to reach USD 36.0 billion by 2040, growing at a CAGR of 30.1% over the forecast period 2026 to 2040, driven by clinical trust, traceable answers, and EHR-grounded AI workflows. Based on deployment model, cloud-based deployment captures 61.0% market share in 2026, whereas hybrid deployment registers a 35.1% CAGR through 2040, driven by protected health data controls. Based on application, clinical d...

The global infusion pumps market size is valued at USD 13.90 billion in 2025 and projected to grow from USD 14.87 billion 2026 to USD 25.39 billion in 2035, representing a CAGR of 6.1% during the forecast period 2026 to 2035. In terms of device type, volumetric pumps currently hold the largest share (30%) due to their high precision, safety, versatility, and broad applications in healthcare (including blood infusion, drug administration, fluid transmission during surgeries, nutrient delivery). A...

The global prescription DTx market is expected to rise from USD 5.8 billion in 2026 to reach USD 75.0 billion by 2040, growing at a CAGR of 20.1% over the forecast period 2026 to 2040, driven by reimbursement pathways, FDA-cleared software therapies, and chronic-care digitization. Based on geography, North America captures 44.0% market share in 2026, whereas Asia-Pacific registers a 23.0% CAGR through 2040, driven by localized reimbursement and regulatory pathways. Based on application, diabetes...

The small molecule API manufacturing market, valued at USD 197 billion in 2025, is projected to reach USD 204 billion in 2026 and USD 266 billion by 2035, representing a CAGR of 3.0% during the forecast period 2026 to 2035. In terms of type of manufacturers, the in-house manufacturers are likely to secure ~65% of the overall revenue share in 2026, due to the growing preference towards large, vertically integrated pharmaceutical companies. In March 2026, Cambrex announced the initial completion o...

The global GLP-1 manufacturing market is expected to rise from USD 14.6 billion in 2026 to reach USD 88.5 billion by 2040, growing at a CAGR of 13.7% over the forecast period 2026 to 2040, driven by chronic obesity and cardiometabolic demand. Based on manufacturing stage, drug substance / peptide API synthesis captures 35.0% market share in 2026, whereas device assembly and secondary packaging registers a 16.5% CAGR through 2040, driven by pen and combination-product scale-up. Based on manufactu...

The global cell encapsulation market, valued at USD 5.0 billion in 2025, is projected to reach USD 5.7 billion in 2026 and USD 15.8 billion by 2035, representing a CAGR of 12.0% during the forecast period 2026 to 2035. In April 2026, Atelerix signed a strategic partnership agreement with JH Health to expand the distribution and use of its proprietary non-cryogenic hydrogel encapsulation and cell preservation technology in the Middle East. In March 2026, researchers at MIT published findings on a...

The global stroke AI market is expected to rise from USD 0.44 billion in 2026 to reach USD 8.05 billion by 2040, growing at a CAGR of 23.1% over the forecast period 2026 to 2040, driven by time-critical stroke detection, care-team activation, and automated treatment-routing workflows. Based on offering, AI imaging and triage software captures 47.0% market share in 2026, whereas analytics and performance-management services register a 28.4% CAGR through 2040, driven by outcomes tracking. Based on...